The modification of gastrointestinal tolerance and responses to abdominal irradiation by chemotherapeutic agents.
Groups of male DBA/2 mice were irradiated with partial abdominal exposures of x radiation ranging from 100 to 1,600 rads. Concomitant with radiation exposure and at 1 or 4 hours prior to, and at 1, 6, 24, or 48 hours after irradiation, various chemotherapeutic agents were administered, i.e., methotrexate, Cytoxan, adriamycin and BCNU. The results suggest that excessive gastrointestinal toxicity may result if aggressive chemotherapy is closely spaced with radiation exposure for the treatment of abdominal neoplasms. However, adjustment of dose and time patterns based on the proliferative responses of the mucosa may circumvent such toxicity to a large extent.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002330:Carmustine / Q000009:adverse effects; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D003520:Cyclophosphamide / Q000009:adverse effects; D007413:Intestinal Mucosa / Q000187:drug effects; D007422:Intestines / Q000528:radiation effects*; D007928:Lethal Dose 50; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D051379:Mice; D008811:Mice, Inbred DBA; D011830:Radiation Effects; D013270:Stomach / Q000528:radiation effects*; D013997:Time Factors
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D002330:Carmustine; D008727:Methotrexate